AgelessRx

AgelessRx, established in 2019 in Michigan, specializes in anti-aging treatments utilizing longevity science to enhance health and vitality. The company focuses on injectable therapies to improve energy, muscle mass, and cognitive function for a diverse clientele. AgelessRx operates from its headquarters in Ann Arbor, Michigan, and focuses on providing anti-aging solutions through scientifically backed therapies. Founded in 2019, it has completed one investment deal, raising USD 5.

473 mn in Series A funding on January 12, 2026, bringing its total funding to USD 5. 473 mn. Details about the founder's prior ventures were not disclosed. AgelessRx specializes in anti-aging treatments that leverage the latest longevity science to enhance health and vitality.

The company offers a range of therapeutic options designed to improve energy levels, lean muscle mass, and cognitive focus, primarily through injectable treatments such as Sermorelin. These products aim to address age-related decline by providing users with scientifically backed solutions for health optimization. AgelessRx serves a diverse clientele, including individuals seeking to manage the effects of aging and those interested in preventative health measures. The company's services are available throughout the United States, catering to a broad customer base focused on wellness, longevity, and enhanced quality of life.

AgelessRx generates revenue through direct-to-consumer sales of its prescription-based products, which include flagship offerings like Sermorelin and other longevity-focused therapies. Customers typically engage with the company by completing a medical intake form that is reviewed by licensed medical providers who determine the appropriateness of prescribed treatments. Following this evaluation, patients have the option to purchase prescribed products that are shipped directly to them, ensuring accessibility and convenience. The revenue model includes subscription services for ongoing medication refills and health support, enhancing the overall patient experience and fostering long-term relationships.

Transactions are processed through online platforms, allowing for efficient management of orders and patient care. AgelessRx plans to utilize the recent Series A funding of USD 5. 473 mn to support the development and launch of new anti-aging products, with potential releases anticipated in 2026. The company aims to expand its market reach beyond the United States, targeting international markets by the end of 2026 to broaden its customer base.

These initiatives will enhance its product offerings and increase accessibility to its anti-aging therapies.